Australis Capital Inc. (AUSAF)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Jul 15, 2025, 4:00 PM EDT
Australis Capital Company Description
Australis Capital Inc. operates as a cannabis company.
It undertakes cannabis and non-cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, Kuwait, Southeast Asia, and Australia, as well as other jurisdictions.
The company was incorporated in 2015 and is headquartered in Las Vegas, Nevada.
Australis Capital Inc.
| Country | Canada |
| Founded | 2015 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Terrance Booth |
Contact Details
Address: 376 East Warm Springs Road Las Vegas, Alberta 89119 United States | |
| Phone | 800 898 0648 |
| Website | ausacap.com |
Stock Details
| Ticker Symbol | AUSAF |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | CAD |
| ISIN Number | CA05259R1073 |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| Terrance R. Booth | Chief Executive Officer and Director |
| Dr. Jason Ronald Bradley Dyck Ph.D. | Chief Science Officer, Chairman of Scientific Advisory Board and Director |
| Robert Wilson | Chief Financial Officer |
| Roger Sykes | Chief Operating Officer |
| Paul E. Larsen | General Counsel |
| Marc Lakmaaker | Senior Vice President of Communications and Capital Markets |
| Fausto Aceituno Aceituno | Chief Marketing Officer |
| W. Campbell Birge B.A., BED, M.Sc. | Strategic Advisor |
| Randon Marcos | Director of Business Development |